tiprankstipranks
Company Announcements

PuraPharm Advances Capital Restructuring with Court Approval

Story Highlights
PuraPharm Advances Capital Restructuring with Court Approval

Discover the Best Stocks and Maximize Your Portfolio:

PuraPharm Corp. Ltd. ( (HK:1498) ) has shared an announcement.

PuraPharm Corporation Limited announced a significant update regarding its proposed capital reduction and subdivision of unissued shares. The court in the Cayman Islands confirmed the capital reduction on January 28, 2025, and the process is now pending registration with the Registrar of Companies. Once registered, the capital reduction and subdivision will be effective, with new ordinary shares expected to commence trading on March 24, 2025. This move is expected to streamline the company’s share structure, potentially enhancing its market positioning and operational efficiency.

More about PuraPharm Corp. Ltd.

Average Trading Volume: 87,514

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$217.2M

Learn more about 1498 stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1